About Rxilient
Rxilient is a company based in Singapore (Singapore) founded in 2021. It operates as a B2B, and Partnership-based. Rxilient offers products and services including Therapeutic Solutions, Pipeline Portfolio, and Commercial Solutions. Rxilient operates in a competitive market with competitors including MiNA Therapeutics, Alentis Therapeutics, Hepion Pharmaceuticals, Ellex and EYE TECH CARE, among others.
- Headquarter Singapore, Singapore
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Rxilient Health Pte. Ltd.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Rxilient
Rxilient offers a comprehensive portfolio of products and services, including Therapeutic Solutions, Pipeline Portfolio, and Commercial Solutions. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Offers innovative medical products for various therapeutic areas.
Manages commercialization and supply chain for licensed brands.
Provides customized strategies for market expansion in healthcare.
Funding Insights of Rxilient
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Rxilient
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Rxilient
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Rxilient Comparisons
Competitors of Rxilient
Rxilient operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MiNA Therapeutics, Alentis Therapeutics, Hepion Pharmaceuticals, Ellex and EYE TECH CARE, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Small activating RNA therapeutics are developed to restore gene function.
|
|
| domain | founded_year | HQ Location |
Therapies for fibrosis, cirrhosis, and liver cancer are developed.
|
|
| domain | founded_year | HQ Location |
Provides therapeutics for chronic liver disorder
|
|
| domain | founded_year | HQ Location |
Develops products for the treatment of eye diseases
|
|
| domain | founded_year | HQ Location |
Ultrasound device for glaucoma treatment is developed.
|
|
| domain | founded_year | HQ Location |
Embolisation-based technology for cancer treatment is developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Rxilient
Frequently Asked Questions about Rxilient
When was Rxilient founded?
Rxilient was founded in 2021.
Where is Rxilient located?
Rxilient is headquartered in Singapore, Singapore.
What does Rxilient do?
Rxilient is a strategic partner in pharmaceutical commercialization, focusing on innovative medical products and solutions across various therapeutic areas. It partners with healthcare companies to expand in emerging markets like Southeast Asia, Taiwan, Middle East, and North Africa. Headquartered in Singapore with global offices, it handles manufacturing, supply chain, and commercialization to build resilient healthcare systems and meet patient needs.
Who are the top competitors of Rxilient?
Rxilient's top competitors include MiNA Therapeutics, Alentis Therapeutics and Hepion Pharmaceuticals.
What products or services does Rxilient offer?
Rxilient offers Therapeutic Solutions, Pipeline Portfolio, and Commercial Solutions.